2 recruiting, 1 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Young Adult: new trials by email Literature Review of Young Adult trials Research Report on Young Adult
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors DNX-2401 - High Grade Glioma, Ependymoma | Phase 2 | Recruiting | Clinica Universidad de Navarra, Universidad de Navarra | 39 | 2026-05-12 | 2026-05-27 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Phentermine, Immediate Release Topiramate, Placebo for Phentermine - Obesity, Morbid, Bariatric Surgery | Phase 2 | Completed | University of Colorado, Denver | 13 | 2020-01-15 | 2025-05-23 |
Ependymoma (1) · Glioma (1) · Obesity, Morbid (1) · Recurrence (1)
Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Disease Attributes (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Obesity (1) · Overnutrition (1) · Overweight (1)
Brentuximab Vedotin (1) · Cyclophosphamide (1) · Dacarbazine (1) · Doxorubicin (1) · Etoposide (1) · Injections (1) · Phentermine (1) · Prednisone (1) · Topiramate (1) · tislelizumab (1)
Children's Cancer Group, China (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · University of Colorado, Denver (1)
China (1) · Netherlands (1) · Spain (1) · United States (1)
P30DK048520 (1)